JANE JAMES: Open Payments
NPI 1104468040 · LOCKPORT, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$749 in 40 payments from 17 companies in 2025. Trend: 2023 $14 · 2024 $331 · 2025 $749
Food & beverage: $749
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 12 | $202 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $74 |
| Novo Nordisk Inc | 3 | $62 |
| Abbott Laboratories | 2 | $56 |
| Merck Sharp & Dohme LLC | 2 | $46 |
| Phathom Pharmaceuticals, Inc. | 3 | $37 |
| PFIZER INC. | 2 | $34 |
| Corcept Therapeutics | 2 | $33 |
| ABBVIE INC. | 1 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
Products named: TRELEGY ELLIPTA, CAPLYTA, SHINGRIX, FREESTYLE LIBRE 3, Ozempic, VOQUEZNA, Korlym, QULIPTA.
Industry payments across NY — which companies pay providers there.
